PROTECTIVE RIGHTS AGREEMENTProtective Rights Agreement • June 5th, 2023 • MEI Pharma, Inc. • Pharmaceutical preparations • New York
THIS PROTECTIVE RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of March 11, 2019 by and between Infinity Pharmaceuticals, Inc., a Delaware corporation (“Grantor”), and HCR Collateral Management, LLC, a Delaware limited liability company (“Agent”), as agent for HealthCare Royalty Partners III, L.P., a Delaware limited partnership (“HC Royalty”).
EXECUTION VERSION PROTECTIVE RIGHTS AGREEMENTProtective Rights Agreement • May 5th, 2020 • New York
THIS PROTECTIVE RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of December 21, 2016 by and between XOMA (US) LLC, a Delaware limited liability company (“Grantor”), and HealthCare Royalty Partners II, L.P., a Delaware limited partnership (“HC Royalty”).
CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. DOUBLE ASTERISKS DENOTE SUCH OMISSIONS. ROYALTY INTEREST ACQUISITION AGREEMENT Dated as of April 22, 2016 between Aviragen Therapeutics, Inc., Biota...Protective Rights Agreement • July 1st, 2021 • Healthcare Royalty, Inc. • Pharmaceutical preparations • New York
This ROYALTY INTEREST ACQUISITION AGREEMENT is made and entered into as of April 22, 2016 by and between Aviragen Therapeutics, Inc. (formerly known as Biota Pharmaceuticals, Inc.), a Delaware corporation (“Aviragen”), Biota Holdings Pty Ltd (formerly known as Biota Holdings Limited), a corporation organized and existing under the laws of Victoria, Australia (“BHPL”), Biota Scientific Management Pty. Ltd., a corporation organized and existing under the laws of Victoria, Australia (“BSM”), and HealthCare Royalty Partners III, L.P., a limited partnership organized under the laws of the State of Delaware (the “Agreement”).
PROTECTIVE RIGHTS AGREEMENTProtective Rights Agreement • May 10th, 2010 • Stratasys Inc • Computer peripheral equipment, nec • Delaware
This Protective Rights Agreement (the “Agreement”) is entered into as of January 18, 2010, by and between Stratasys, Inc. (the “Company”), a Delaware corporation, having a principal place of business at 7665 Commerce Way, Eden Prairie, Minnesota 55344-2020, and Hewlett-Packard Company (“HP”), a Delaware corporation, having a principal place of business at 3000 Hanover Street, Palo Alto, California 94304.
ROYALTY INTEREST ACQUISITION AGREEMENT Dated as of December 20, 2016 between XOMA Corporation and XOMA (US) LLC and HealthCare Royalty Partners II, L.P.Protective Rights Agreement • March 16th, 2017 • XOMA Corp • Pharmaceutical preparations • New York
This ROYALTY INTEREST ACQUISITION AGREEMENT (this “Agreement”) is made and entered into as of December 20, 2016 by and between XOMA Corporation, a corporation organized under the laws of the State of Delaware (“XOMA”) and XOMA (US) LLC, a limited liability company organized under the laws of the State of Delaware (“Seller”), and HealthCare Royalty Partners II, L.P., a limited partnership organized under the laws of the State of Delaware (“Buyer”).
ContractProtective Rights Agreement • April 26th, 2016 • Aviragen Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York
